Avalo Therapeutics (trading under ticker AVTX) is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing targeted therapeutics and monoclonal antibodies. Its research pipeline is dedicated to addressing severe immune-mediated inflammatory diseases and autoimmune conditions with significant unmet medical needs through advanced immunological pathways.